The value of FDG-PET in the diagnosis of thromboangiitis obliterans--a case series
- PMID: 24794493
- DOI: 10.1007/s10067-014-2648-5
The value of FDG-PET in the diagnosis of thromboangiitis obliterans--a case series
Abstract
Thromboangiitis obliterans (TAO) is an inflammatory vascular disease affecting dominantly the vessels of the extremities and is etiologically strongly associated with tobacco consumption. Different imaging techniques are generally used to exclude potential differential diagnoses. We investigated the value of (18) F-flourodeoxyglucose positron emission tomography ([(18) F]FDG-PET) in the diagnosis of TAO. All consecutive patients with diagnosed TAO between Nov 2001 and Nov 2003 at our institution who underwent [(18) F]FDG-PET in the diagnostic workup were analyzed retrospectively. Whole-body scans were conducted after a fasting period of at least 6 h and blood glucose levels lower than 180 mg/dl. The primary endpoint was defined as significantly increased vascular FDG uptake. Tracer uptake was visually determined and, in accordance with strength, divided into grades 0 to 3. In total, ten patients were statistically evaluated. The median patient age at the date of the first [(18) F]FDG-PET was 41.5 years. Repetitive FDG-PET imaging was performed in seven out of ten patients (70 %). The endpoint was objectified in one of the initial examinations (10 %) and in another one out of seven follow-up scans (14.3 %). One positive [(18) F]FDG-PET was observed in the pelvic vessels and the other in the infrapopliteal arteries. Therefore, increased tracer uptake could be observed in two examinations on two different patients (both with grade 3 tracer uptake) out of 17 conducted [(18) F]FDG-PETs in total. The [(18) F]FDG-PET was not a suitable investigative procedure for the diagnosis of TAO in the present patient cohort.
Similar articles
-
More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT.Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7. Hell J Nucl Med. 2019. PMID: 30843003
-
Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI.Eur J Nucl Med Mol Imaging. 2003 May;30(5):730-6. doi: 10.1007/s00259-003-1144-y. Epub 2003 Apr 4. Eur J Nucl Med Mol Imaging. 2003. PMID: 12677302 Clinical Trial.
-
The role of F-18-fluorodeoxyglucose positron emission tomography in the postoperative evaluation of differentiated thyroid cancer.Eur J Endocrinol. 2008 May;158(5):683-9. doi: 10.1530/EJE-07-0903. Eur J Endocrinol. 2008. PMID: 18426827 Clinical Trial.
-
Clinical value of ¹⁸F-fluoro-dexoxyglucose positron emission tomography/computed tomography in patients with adult-onset Still's disease: a seven-case series and review of the literature.Mod Rheumatol. 2014 Jul;24(4):645-50. doi: 10.3109/14397595.2013.850998. Epub 2013 Nov 4. Mod Rheumatol. 2014. PMID: 24252024 Review.
-
18F-FDG PET/CT in sarcoidosis management: review and report of 20 cases.Eur J Nucl Med Mol Imaging. 2008 Aug;35(8):1537-43. doi: 10.1007/s00259-008-0770-9. Epub 2008 Apr 17. Eur J Nucl Med Mol Imaging. 2008. PMID: 18418595 Review.
Cited by
-
Alkynyl-containing phenylthiazoles: Systemically active antibacterial agents effective against methicillin-resistant Staphylococcus aureus (MRSA).Eur J Med Chem. 2018 Mar 25;148:195-209. doi: 10.1016/j.ejmech.2018.02.031. Epub 2018 Feb 12. Eur J Med Chem. 2018. PMID: 29459278 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources